167 related articles for article (PubMed ID: 17916042)
1. The future of cell therapies in the treatment of Parkinson's disease.
Laguna Goya R; Kuan WL; Barker RA
Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
[TBL] [Abstract][Full Text] [Related]
2. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
Beaulieu-Boire I; Fasano A
Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
[No Abstract] [Full Text] [Related]
3. Cellular replacement therapy for Parkinson's disease--where we are today?
Redmond DE
Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
[TBL] [Abstract][Full Text] [Related]
4. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
Barker RA; Kuan WL
Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
[TBL] [Abstract][Full Text] [Related]
5. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
[TBL] [Abstract][Full Text] [Related]
6. Update on fetal transplantation: the Swedish experience.
Lindvall O
Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
[TBL] [Abstract][Full Text] [Related]
7. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
[TBL] [Abstract][Full Text] [Related]
8. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson's disease.
Bhattacharya N; Chhetri MK; Mukherjee KL; Ghosh AB; Samanta BK; Mitra R; Bhattacharya M; Bhattacharya S; Bandopadhyaya T
Clin Exp Obstet Gynecol; 2002; 29(4):259-66. PubMed ID: 12635741
[TBL] [Abstract][Full Text] [Related]
9. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease.
Mamelak AN; Eggerding FA; Oh DS; Wilson E; Davis RL; Spitzer R; Hay JA; Caton WL
J Neurosurg; 1998 Oct; 89(4):592-8. PubMed ID: 9761053
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of embryonic porcine mesencephalic tissue in patients with PD.
Schumacher JM; Ellias SA; Palmer EP; Kott HS; Dinsmore J; Dempsey PK; Fischman AJ; Thomas C; Feldman RG; Kassissieh S; Raineri R; Manhart C; Penney D; Fink JS; Isacson O
Neurology; 2000 Mar; 54(5):1042-50. PubMed ID: 10720272
[TBL] [Abstract][Full Text] [Related]
11. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease.
Molenaar GJ; Hogenesch RI; Sprengers ME; Staal MJ
J Comp Neurol; 1997 May; 382(1):19-28. PubMed ID: 9136809
[TBL] [Abstract][Full Text] [Related]
12. Dyskinesias after transplantation in Parkinson's disease.
Piccini P
Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
[No Abstract] [Full Text] [Related]
13. CNS immunological modulation of neural graft rejection and survival.
Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation: a promising therapy for Parkinson's disease.
Wang Y; Chen S; Yang D; Le WD
J Neuroimmune Pharmacol; 2007 Sep; 2(3):243-50. PubMed ID: 18040857
[TBL] [Abstract][Full Text] [Related]
15. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?
Liu J; Huang HY
Neurosci Bull; 2007 Nov; 23(6):377-82. PubMed ID: 18064069
[TBL] [Abstract][Full Text] [Related]
16. Dyskinesias following neural transplantation in Parkinson's disease.
Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
[TBL] [Abstract][Full Text] [Related]
17. Neuroscience. Fetal cells again?
Holden C
Science; 2009 Oct; 326(5951):358-9. PubMed ID: 19833936
[No Abstract] [Full Text] [Related]
18. Neural transplantation for the treatment of Parkinson's disease.
Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
[No Abstract] [Full Text] [Related]
19. Current status of clinical trials of neural transplantation in Parkinson's disease.
Evans JR; Mason SL; Barker RA
Prog Brain Res; 2012; 200():169-98. PubMed ID: 23195419
[TBL] [Abstract][Full Text] [Related]
20. Neural transplantation, trophic factors and Parkinson's disease.
Kupsch A; Oertel WH
Life Sci; 1994; 55(25-26):2083-95. PubMed ID: 7997067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
